Literature DB >> 6259980

Cytomegalovirus retinitis in immunosuppressed hosts. II. Ocular manifestations.

P R Egbert, R B Pollard, J G Gallagher, T C Merigan.   

Abstract

We observed the course of cytomegalovirus (CMV) retinitis in 21 eyes of 14 immunosuppressed patients. In two patients, other organisms, specifically Toxoplasma and Candida, also appeared to be causing retinal disease simultaneously. Post-mortem examination was done on 10 eyes from seven patients. At initial presentation, the retinitis was often asymptomatic and diagnosed during routine examination. The ophthalmoscopic picture was characteristic of cytomegalovirus; the early lesion was a small opaque, white granular area of retinal necrosis that spread in a centrifugal, brush-fire-like manner over 1 to 8 months. Vessel sheating and hemorrhages appeared as the disease progressed. In two patients new foci of retinitis developed remote from the original lesion. Four weeks to 4 months (average, 10 weeks) elapsed from the most extensive disease to total resolution. Resolution of active disease left a subtle retinal scar, and final visual acuity was reduced in one half the eyes. Repeated ophthalmoscopic examinations can aid in early diagnosis of CMV retinitis and in ascertaining which persons are most at risk for visual loss.

Entities:  

Mesh:

Year:  1980        PMID: 6259980     DOI: 10.7326/0003-4819-93-5-664

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  25 in total

1.  Treatment of cytomegalovirus retinitis with DHPG in a patient with AIDS.

Authors:  J M Hooymans; H G Sprenger; J Weits
Journal:  Doc Ophthalmol       Date:  1987 Sep-Oct       Impact factor: 2.379

2.  Pathogenesis of murine cytomegalovirus infection: identification of infected cells in the spleen during acute and latent infections.

Authors:  J A Mercer; C A Wiley; D H Spector
Journal:  J Virol       Date:  1988-03       Impact factor: 5.103

3.  Progressive cytomegalovirus encephalopathy following congenital infection in an infant with acquired immunodeficiency syndrome.

Authors:  R G Curless; G B Scott; M J Post; J B Gregorios
Journal:  Childs Nerv Syst       Date:  1987       Impact factor: 1.475

4.  CD8+ T lymphocytes in cytomegalovirus retinitis in a patient with AIDS.

Authors:  S Oka; Y Nagata; Y Fujino; A Yasuoka; N Tachikawa; K Shimada; S Kimura; A Iwamoto; M Mochizuki
Journal:  Br J Ophthalmol       Date:  1996-12       Impact factor: 4.638

5.  Bilateral cytomegalovirus retinitis in a patient with systemic lupus erythematosus.

Authors:  R O Schlingemann; P Wertheim-van Dillen; A Kijlstra; P J Bos; C Meenken; E J Feron
Journal:  Br J Ophthalmol       Date:  1996-12       Impact factor: 4.638

6.  Induction by sodium butyrate of cytomegalovirus replication in human endothelial cells.

Authors:  K Radsak; R Fuhrmann; R P Franke; D Schneider; A Kollert; K H Brücher; D Drenckhahn
Journal:  Arch Virol       Date:  1989       Impact factor: 2.574

7.  Atypical presumed CMV retinitis.

Authors:  K W To; A J Nadel
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1989       Impact factor: 3.117

Review 8.  The status of CMV as a human pathogen.

Authors:  P D Griffiths; J E Grundy
Journal:  Epidemiol Infect       Date:  1988-02       Impact factor: 2.451

9.  Infected T98G glioblastoma cells support human cytomegalovirus reactivation from latency.

Authors:  Shuang Cheng; Xuan Jiang; Bo Yang; Le Wen; Fei Zhao; Wen-Bo Zeng; Xi-Juan Liu; Xiao Dong; Jin-Yan Sun; Ying-Zi Ming; Hua Zhu; Simon Rayner; Qiyi Tang; Elizabeth Fortunato; Min-Hua Luo
Journal:  Virology       Date:  2017-07-24       Impact factor: 3.616

10.  Alpha-interferon administration in cytomegalovirus retinitis.

Authors:  S W Chou; J S Dylewski; M W Gaynon; P R Egbert; T C Merigan
Journal:  Antimicrob Agents Chemother       Date:  1984-01       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.